Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes Pursuant to 21 U.S.C 952; DEA Form 357, 56703 [2016-19916]

Download as PDF Federal Register / Vol. 81, No. 162 / Monday, August 22, 2016 / Notices 56703 —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and Dated: lllllllllllllllll —Minimize the burden of the collection lllllllllllllllllllll of information on those who are to United States District Judge respond, including through the use of [FR Doc. 2016–19988 Filed 8–19–16; 8:45 am] appropriate automated, electronic, BILLING CODE P mechanical, or other forms of information technology, e.g., permitting electronic submission of DEPARTMENT OF JUSTICE responses. proposed collection: The DEA estimates the total public burden (in hours) associated with this collection: 333 annual burden hours. If additional information is required please contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC 20530. [OMB Number 1117–0013] Dated: August 16, 2016. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. IV. Entry of this Final Judgment is in the public interest. Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes Pursuant to 21 U.S.C 952; DEA Form 357 Drug Enforcement Administration, Department of Justice. ACTION: 60-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until October 21, 2016. FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Michael J. Lewis, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; asabaliauskas on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:13 Aug 19, 2016 Jkt 238001 Overview of this information collection: 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes pursuant to 21 U.S.C. 952. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Form: 357. The applicable component within the Department of Justice is the Drug Enforcement Administration, Office of Diversion Control. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): None. Abstract: Section 1002 of the Controlled Substances Import and Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal Regulations (21 CFR), Sections 1312.11, 1312.12 and 1312.13 requires any person who desires to import controlled substances listed in schedules I or II, any narcotic substance listed in schedules III or IV, or any non-narcotic substance in schedule III which the Administrator has specifically designated by regulation in § 1312.30, or any nonnarcotic substance in schedule IV or V which is also listed in schedule I or II of the Convention on Psychotropic Substances, must have an import permit. To obtain the permit to import controlled substances for domestic and or scientific purposes, an application for the permit must be made to the DEA on DEA Form 357. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 151 registrants participate in this information collection, taking an estimated 0.25 hours per registrant annually. 6. An estimate of the total public burden (in hours) associated with the PO 00000 Frm 00127 Fmt 4703 Sfmt 4703 [FR Doc. 2016–19916 Filed 8–19–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Office of the Secretary Agency Information Collection Activities; Submission for OMB Review; Comment Request; Survey of Occupational Injuries and Illnesses ACTION: Notice. The Department of Labor (DOL) is submitting the Bureau of Labor Statistics (BLS) sponsored information collection request (ICR) revision titled, ‘‘Survey of Occupational Injuries and Illnesses,’’ to the Office of Management and Budget (OMB) for review and approval for use in accordance with the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501 et seq.). Public comments on the ICR are invited. DATES: The OMB will consider all written comments that agency receives on or before September 21, 2016. ADDRESSES: A copy of this ICR with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained free of charge from the RegInfo.gov Web site at http:// www.reginfo.gov/public/do/ PRAViewICR?ref_nbr=201606–1220–001 (this link will only become active on the day following publication of this notice) or by contacting Michel Smyth by telephone at 202–693–4129, TTY 202– 693–8064, (these are not toll-free numbers) or sending an email to DOL_ PRA_PUBLIC@dol.gov. Submit comments about this request by mail or courier to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for DOL–BLS, Office of Management and Budget, Room 10235, 725 17th Street NW., Washington, DC 20503; by Fax: 202– SUMMARY: E:\FR\FM\22AUN1.SGM 22AUN1

Agencies

[Federal Register Volume 81, Number 162 (Monday, August 22, 2016)]
[Notices]
[Page 56703]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19916]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0013]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection; Application for Permit to Import Controlled Substances for 
Domestic and/or Scientific Purposes Pursuant to 21 U.S.C 952; DEA Form 
357

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995.

DATES: Comments are encouraged and will be accepted for 60 days until 
October 21, 2016.

FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated 
public burden or associated response time, suggestions, or need a copy 
of the proposed information collection instrument with instructions or 
additional information, please contact Michael J. Lewis, Office of 
Diversion Control, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 
598-6812.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other forms of information technology, e.g., 
permitting electronic submission of responses.

    Overview of this information collection:
    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Application for Permit to Import 
Controlled Substances for Domestic and/or Scientific Purposes pursuant 
to 21 U.S.C. 952.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Form: 357. The applicable 
component within the Department of Justice is the Drug Enforcement 
Administration, Office of Diversion Control.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): None.
    Abstract: Section 1002 of the Controlled Substances Import and 
Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal 
Regulations (21 CFR), Sections 1312.11, 1312.12 and 1312.13 requires 
any person who desires to import controlled substances listed in 
schedules I or II, any narcotic substance listed in schedules III or 
IV, or any non-narcotic substance in schedule III which the 
Administrator has specifically designated by regulation in Sec.  
1312.30, or any nonnarcotic substance in schedule IV or V which is also 
listed in schedule I or II of the Convention on Psychotropic 
Substances, must have an import permit. To obtain the permit to import 
controlled substances for domestic and or scientific purposes, an 
application for the permit must be made to the DEA on DEA Form 357.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 151 registrants participate in this information collection, taking 
an estimated 0.25 hours per registrant annually.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates the total public burden 
(in hours) associated with this collection: 333 annual burden hours.

If additional information is required please contact: Jerri Murray, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC 
20530.

    Dated: August 16, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-19916 Filed 8-19-16; 8:45 am]
 BILLING CODE 4410-09-P